Los puntos clave no están disponibles para este artículo en este momento.
Despite advances in diabetes technologies, medications, and dissemination of more aggressive glycemic targets, many current YYA are less likely to achieve desired glycemic control relative to earlier cohorts.
Malik et al. (Fri,) studied this question.